Amy Comander
0000-0002-1644-9297
4 papers found
Refreshing results…
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial
Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast)
Remember Your Why … An Oncologist's Reflections on Running During the COVID ‐19 Pandemic
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update
Missing publications? Search for publications with a matching author name.